USANA Health Sciences (USNA) Misses Q4 EPS by 16c; Issues Light FY16 Outlook

USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.83, $0.16 worse than the analyst estimate of $1.99. Revenue for the quarter came in at $232.6 million versus the consensus estimate of $238.91 million.

GUIDANCE:

USANA Health Sciences sees FY2016 EPS of $7.60-$8.15, versus the consensus of $8.59. USANA Health Sciences sees FY2016 revenue of $1.02-1.05 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c